In favor of a ‘spreading’ model of pathology, tau is also detected in the brain interstitial fluid (ISF) of transgenic mice [122] and in the CSF of AD patients, where both tau and P-Tau are elevated, suggesting a role for extracellular tau in disease pathogenesis and/or a consequence of disease progression. The gene discussed is MAPT; the disease is Alzheimer disease.